Brian Goff - Net Worth and Insider Trading
Brian Goff Net Worth
The estimated net worth of Brian Goff is at least $9 Million dollars as of 2024-12-26. Brian Goff is the EVP & Chief Commercial Officer of Alexion Pharmaceuticals Inc and owns about 36,257 shares of Alexion Pharmaceuticals Inc (ALXN) stock worth over $7 Million. Brian Goff is also the CEO of Agios Pharmaceuticals Inc and owns about 78,792 shares of Agios Pharmaceuticals Inc (AGIO) stock worth over $3 Million. Details can be seen in Brian Goff's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Brian Goff has not made any transactions after 2024-08-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Brian Goff
Brian Goff Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Brian Goff owns 3 companies in total, including Alexion Pharmaceuticals Inc (ALXN) , Baxalta Inc (BXLT) , and Agios Pharmaceuticals Inc (AGIO) .
Click here to see the complete history of Brian Goff’s form 4 insider trades.
Insider Ownership Summary of Brian Goff
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ALXN | Alexion Pharmaceuticals Inc | 2020-06-08 | EVP & Chief Commercial Officer |
BXLT | Baxalta Inc | 2016-06-03 | EVP and President & Hematology |
AGIO | Agios Pharmaceuticals Inc | 2024-08-08 | director & Chief Executive Officer |
Brian Goff Latest Holdings Summary
Brian Goff currently owns a total of 2 stocks. Among these stocks, Brian Goff owns 36,257 shares of Alexion Pharmaceuticals Inc (ALXN) as of June 8, 2018, with a value of $7 Million and a weighting of 70.96%. Brian Goff also owns 78,792 shares of Agios Pharmaceuticals Inc (AGIO) as of August 8, 2024, with a value of $3 Million and a weighting of 29.04%.
Latest Holdings of Brian Goff
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ALXN | Alexion Pharmaceuticals Inc | 2018-06-08 | 36,257 | 182.50 | 6,616,903 |
AGIO | Agios Pharmaceuticals Inc | 2024-08-08 | 78,792 | 34.37 | 2,708,081 |
Holding Weightings of Brian Goff
Brian Goff Form 4 Trading Tracker
According to the SEC Form 4 filings, Brian Goff has made a total of 0 transactions in Alexion Pharmaceuticals Inc (ALXN) over the past 5 years. The most-recent trade in Alexion Pharmaceuticals Inc is the sale of 1,645 shares on June 8, 2018, which brought Brian Goff around $194,982.
According to the SEC Form 4 filings, Brian Goff has made a total of 6 transactions in Agios Pharmaceuticals Inc (AGIO) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Agios Pharmaceuticals Inc is the sale of 11,091 shares on August 8, 2024, which brought Brian Goff around $474,140.
Insider Trading History of Brian Goff
- 1
Brian Goff Trading Performance
Brian Goff Ownership Network
Brian Goff Owned Company Details
What does Alexion Pharmaceuticals Inc do?
Who are the key executives at Alexion Pharmaceuticals Inc?
Brian Goff is the EVP & Chief Commercial Officer of Alexion Pharmaceuticals Inc. Other key executives at Alexion Pharmaceuticals Inc include SVP & Controller & CAO Daniel Bazarko , EVP & CCAO Tanisha Carino , and EVP & Research & Development John J Orloff .
Alexion Pharmaceuticals Inc (ALXN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Alexion Pharmaceuticals Inc (ALXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alexion Pharmaceuticals Inc (ALXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Alexion Pharmaceuticals Inc (ALXN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alexion Pharmaceuticals Inc Insider Transactions
Brian Goff Mailing Address
Above is the net worth, insider trading, and ownership report for Brian Goff. You might contact Brian Goff via mailing address: C/o Alexion Pharmaceuticals, Inc, 100 College Street, New Haven Ct 06510.